The FDA has granted Ethicon Biosurgery, an Ethicon unit, approval for its EVARREST system designed to help control problematic, surgery-related bleeding. The fibrin sealant patch, which is used with manual compression, has been approved as an ancillary tool to hemostasis for soft tissue bleeding in patients undergoing pelvic surgery and other procedures.
Ethicon unit's surgical sealant patch gains FDA approval
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Vice President of Finance||
Urban Health Plan, Inc.
|Director of Payor/Provider Contracting||
U.S. Medical Management